Table 3.
Imaging examinations of patients with gastroenteropancreatic neuroendocrine tumors.
Imaging examination | Usage (%) | Positive rate (%) |
---|---|---|
CT | 68.5 | 58/74 (78.4) |
B-ultrasonics | 30.6 | 20/33 (60.6) |
MRI | 19.4 | 20/21 (95.2) |
Endoscope | 47.2 | 51/51 (100) |
PET/CT | 2.8 | 2/3 (66.7) |
SPECT | 0.9 | 1/1 (100%) |